Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Environmental Science & Technology|August 14, 2018
Oil Sands Derived Naphthenic Acids Are Oxidative Uncouplers and Impair Electron Transport in Isolated MitochondriaKate I Rundle, Mahmoud S Sharaf, Don Stevens, et al.
Environmental Pollution (Barking, Essex : 1987)|January 18, 2016
Copper and hypoxia modulate transcriptional and mitochondrial functional-biochemical responses in warm acclimated rainbow trout (Oncorhynchus mykiss)Ravinder Sappal, Mark Fast, Sara Purcell, et al.
Free Radical Biology & Medicine|September 20, 2023
Exhaustive exercise alters native and site-specific H2O2 emission in red and white skeletal muscle mitochondriaCollins Kamunde, Yashodya Wijayakulathilake, Chidozie Okoye, et al.
Diagnostic Microbiology and Infectious Disease|February 23, 2002
Training costs and investment payback of implementing molecular diagnostics for identification of vancomycin resistant enterococci in a clinical microbiology laboratoryBonnie Page, Astrid Petrich, Don Stevens, et al.
The Journal of Biological Chemistry|March 23, 2005
Expression of four glutamine synthetase genes in the early stages of development of rainbow trout (Oncorhynchus mykiss) in relationship to nitrogen excretionPhyllis A Essex-Fraser, Shelby L Steele, Nicholas J Bernier, et al.
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|January 8, 2024
Effect of skeletal muscle mitochondrial phenotype on H2O2 emissionCollins Kamunde, Yashodya Wijayakulathilake, Chidozie Okoye, et al.
Haematologica|September 5, 2024
Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trialTycel Phillips, Michael Wang, Tadeusz Robak, et al.
Blood Cancer Journal|August 21, 2021
Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trialFranck Morschhauser, Nilanjan Ghosh, Izidore S Lossos, et al.
Blood Advances|February 9, 2021
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphomaPanayiotis Panayiotidis, George A Follows, Luigina Mollica, et al.
British Journal of Haematology|March 5, 2019
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA studyHabte Yimer, Jason Melear, Edward Faber, et al.
Pageof 6